US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors

NCT03452644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2023-05-23

No results posted yet for this study

Summary

A retrospective evaluation of soft tissue tumors that have undergone core needle biopsy with US guidance (US-CNB)

Conditions

  • Soft Tissue Neoplasm
  • Soft Tissue Sarcoma
  • Soft Tissue Mass
  • Soft Tissue Lesion

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Alberto Bazzocchi, MD, PhD · The Rizzoli Ortopaedic Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-20
Primary Completion
2019-01-15
Completion
2020-09-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03452644 on ClinicalTrials.gov